Step by Stepa HemeOncBuddy patient portal

Carboplatin and etoposide

Illustration: Carboplatin and etoposide

Say it: KAR-bo-PLA-tin and ee-TOE-po-side

Carboplatin and etoposide

Carboplatin and etoposide is a two medicine chemotherapy that is the main treatment for small cell lung cancer, often given with an immunotherapy or with radiation.

Also called: carbo etop, carbo/etoposide, carbo VP-16, carboplatin VP-16, CE, EC, EP, cisplatin etoposide, carbo etoposide atezolizumab, carbo etoposide durvalumab, IMpower133 regimen, CASPIAN regimen

What it is

Carboplatin and etoposide damage cancer cells in two different ways. Small cell lung cancer usually shrinks quickly with this treatment. When the cancer has spread, an immunotherapy (atezolizumab or durvalumab) is added to help your immune system keep the cancer under control, and the goal is to shrink it and help you live longer and feel better. When the cancer is only in the chest, chemotherapy is given with radiation and the goal is cure.

Often used for

With atezolizumab (extensive stage)
Atezolizumab, carboplatin and etoposide are given together every 21 days for 4 cycles. Then chemotherapy stops and atezolizumab continues alone every 3 or 4 weeks as long as it is working. For some people, lurbinectedin (another chemotherapy) may be added to atezolizumab during maintenance.
With durvalumab (extensive stage)
Durvalumab, carboplatin (or cisplatin) and etoposide are given together every 21 days for 4 cycles. Then durvalumab continues alone every 4 weeks as long as it is working.
With radiation (limited stage)
For cancer only in the chest, cisplatin and etoposide are most often used, with carboplatin used when cisplatin is not safe. Usually 4 cycles are given every 21 days, with chest radiation starting during the first or second cycle. Radiation is given once a day for about 6 to 7 weeks, or twice a day for about 3 weeks. Afterward, many people get durvalumab every 4 weeks for up to 2 years.
Chemotherapy alone
Carboplatin and etoposide without immunotherapy, usually 4 to 6 cycles, may be used when immunotherapy is not safe, such as for some people with serious autoimmune disease.

The medicines in this plan

Carboplatin
Platinum chemotherapy. Given through a vein over about 30 to 60 minutes on day 1. Your dose is based on how well your kidneys work.
Etoposide
Chemotherapy that stops cancer cells from repairing and copying their DNA. Given through a vein over about 1 hour on days 1, 2 and 3. Sometimes the day 2 and 3 doses are taken as pills at home.
Atezolizumab
Only in the atezolizumab version. Immunotherapy that takes the brakes off your immune system. Given through a vein on day 1, then continued as maintenance.
Durvalumab
Only in the durvalumab version, or after radiation for limited stage. Immunotherapy that works like atezolizumab. Given through a vein over about 1 hour on day 1, then continued as maintenance.
Cisplatin
Only in the cisplatin version. Platinum chemotherapy given through a vein in place of carboplatin, with extra IV fluids to protect the kidneys.

How you get it

Carboplatin and etoposide are given in an outpatient infusion clinic every 21 days, through an IV or a port (a small device placed under the skin of the chest). Day 1 takes about 3 to 4 hours, and days 2 and 3 are shorter visits for etoposide (unless you take etoposide pills at home). Most people get 4 cycles, about 3 months. Then immunotherapy often continues alone. Your schedule may be different.

A typical cycle

Day 1
Blood tests and a check in with your team. Then anti-nausea medicines, then any immunotherapy, then carboplatin and etoposide.
Days 2 and 3
Short clinic visits for IV etoposide, or etoposide pills at home if your team prescribed them.
Days 4 to 7
Tiredness and nausea are most common now. A white blood cell booster shot may be given.
Days 8 to 15
Blood counts are lowest. Watch closely for fever and signs of infection.
Days 16 to 21
Recovery before the next cycle. Scans are usually done every 2 cycles at first.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Lung cancer

Sources

Quick answers

What is Carboplatin and etoposide?
Carboplatin and etoposide is a two medicine chemotherapy that is the main treatment for small cell lung cancer, often given with an immunotherapy or with radiation. Carboplatin and etoposide.
How is Carboplatin and etoposide given?
Carboplatin and etoposide are given in an outpatient infusion clinic every 21 days, through an IV or a port (a small device placed under the skin of the chest). Day 1 takes about 3 to 4 hours, and days 2 and 3 are shorter visits for etoposide (unless you take etoposide pills at home). Most people get 4 cycles, about 3 months. Then immunotherapy often continues alone. Your schedule may be different.
What are the common side effects of Carboplatin and etoposide?
Low blood counts, which are common with this plan and raise the risk of infection, bleeding and tiredness. Hair loss, usually starting 2 to 3 weeks after the first treatment. Tiredness. Nausea and poor appetite. Mouth sores. Constipation or diarrhea. With radiation: sore throat and painful swallowing, cough and skin redness on the chest. With immunotherapy: rash, itching, diarrhea or thyroid changes. With cisplatin: more nausea, ringing in the ears or hearing changes, and tingling in hands and feet.
When should I call my care team during Carboplatin and etoposide?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Trouble breathing, chest tightness, flushing, rash or swelling of the face or throat during or soon after the infusion; New or worse cough, shortness of breath or chest pain; Diarrhea 4 or more times a day above your normal, or blood in your stool; Yellow skin or eyes, or dark urine; Confusion, a very bad headache, new weakness, trouble speaking, a seizure or extreme sleepiness; Not able to keep fluids down, or feeling dizzy when you stand; Swallowing so painful that you cannot eat or drink (during radiation); Bleeding that will not stop, or new bruises you cannot explain.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.